Paul Maier joins Sequenom
This article was originally published in Scrip
Sequenom (US) has appointed Paul Maier interim chief financial officer, effective November 10th. Before his appointment begins, he will act as a consultant to the company. Mr Maier has been an independent financial consultant since February 2007. From 1992 until January 2007, he served as senior vice-president and chief financial officer of Ligand Pharmaceuticals. Before that, he spent six years in various management and finance positions at ICN Pharmaceuticals.